// App-Quantinova.ai

1220-171 : PRE-TRANSPLANT CHEMOTHERAPY DOES NOT AFFECT POST TRANSPLANT OUTCOME IN PATIENTS UNDERGOING OHT FOR AL CARDIOMYOPATHY

Researchers

Presenter

  • Nitasha Sarswat

Principal Investigators

  • Emily Niehaus

  • Sara Tabtabai

  • Marc Semigran

  • James Stone

  • Lauren Gilstrap

  • Matthew Maurer

  • Ronald Witteles

  • Jerry Estep

  • David Baran

  • Mark Zucker

  • David Seldin

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

Disease

  • Cardiac amyloidosis

  • Heart muscle disease

  • Congestive heart failure

  • Amyloid disease

Biomarkers

  • N/A

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Lenalidomide

  • Bortezomib

  • Melphalan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved